Evolution of Alzheimer's disease-related cytoskeletal changes in the basal nucleus of Meynert

Acta Neuropathologica

Volumn 100, Issue 3, 2000, Pages 259-269

  Sassin, Irena ^a   Schultz, Christian ^a   Thal, Dietmar Rudolf ^a   Rüb, Udo ^a   Arai, Kimihito ^a   Braak, Eva ^a   Braak, Heiko ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Alzheimer's disease; Basal nucleus of meynert; Neuronal cytoskeleton; Tau protein

Indexed keywords

AMYLOID BETA PROTEIN; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN CORTEX; CLINICAL ARTICLE; CYTOSKELETON; DISEASE COURSE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MEYNERT BASAL NUCLEUS; NERVE CELL; NEUROFIBRILLARY TANGLE; PARASYMPATHETIC INNERVATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION;

EID: 0033922730     PISSN: 00016322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004019900178     Document Type: Article

References (59)

1. Arendt T, Bigl V, Arendt A, Tennstedt A (1983) Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's disease. Acta Neuropathol (Berl) 61: 101-108
2. Arendt T, Bigl V, Tennstedt A, Arendt A (1985) Neuronal loss in different parts of the nucleus basalis is related to neuritic plaque formation in cortical target areas in Alzheimer's disease. Neuroscience 14: 1-14
3. Arendt T, Taubert G, Bigl V, Arendt A (1988) Amyloid deposition in the nucleus basalis of Meynert complex: a topographic marker for degenerating cell clusters in Alzheimer's disease. Acta Neuropathol (Berl) 75: 226-232
4. Arendt T, Marcova L, Bigl V, Brückner MK (1995) Dendritic reorganisation in the basal forebrain under degenerative conditions and its defects in Alzheimer disease. 1. Dendritic organisation of the normal human basal forebrain. J Comp Neurol 151: 169-188
5. Ashford JW, Soultanian NS, Zhang SX, Geddes JW (1998) Neuropil threads are collinear with MAP2 immunostaining in neuronal dendrites of Alzheimer brain. J Neuropathol Exp Neurol 57: 972-978
6. Bancher C, Brunner C, Lassmann H, Budka H, Jellinger K, Wiche G, Seitelberger F, Grundke-Iqbal I, Iqbal K, Wisniewski HM (1989) Accumulation of abnormally phosphorylated τ precedes the formation of neurofibrillary tangles in Alzheimer's disease. Brain Res 477: 90-99
7. Bancher C, Jellinger K, Lassmann H, Fischer P, Leblhuber F (1996) Correlations between mental state and quantitative neuropathology in the Vienna longitudinal study on dementia. Eur Arch Psychiatry Clin Neurosci 246: 137-146
8. Beach TG, Honer WG, Hughes LH (1997) Cholinergic fibre loss associated with diffuse plaques in the non-demented elderly: the preclinical stage of Alzheimer's disease? Acta Neuropathol 93: 146-153
9. Beach TG, Sue LI, Scott S, Sparks DL (1998) Neurofibrillary tangles are constant in aging human nucleus basalis. Alzheimer Rep 1: 375-380
10. Biernat J, Mandelkow EM, Schröter E, Lichtenberg-Kraag B, Steiner B, Berling B, Meyer H, Mercken M, Vandermeeren A, Goedert M, Mandelkow E (1992) The switch of tau protein to an Alzheimer-like state includes the phosphorylation of two serine-proline motifs upstream of the microtubule binding region. EMBO J 11: 1593-1597
11. Binder LI, Frankfurter A, Rebhun LI (1985) The distribution of tau in the mammalian central nervous system. J Cell Biol 101: 1371-1378
12. Bobinski M, Wegiel J, Tarnawski M, Bobinski M, Leon MJ de, Reisberg B, Miller DC, Wisniewski HM (1998) Duration of neurofibrillary changes in the hippocampal pyramidal neurons. Brain Res 799: 156-158
13. Bondareff W, Harrington C, Wischik CM, Hauser DL, Roth M (1994) Immunohistochemical staging of neurofibrillary degeneration in Alzheimer's disease. J Neuropathol Exp Neurol 53: 158-164
14. Bowen DM, Smith CB, White P, Davison AN (1976) Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies. Brain 99: 459-496
15. Bowen DM, Benton JS, Spillane JA, Smith CCT, Allen SJ (1982) Choline acetyltransferase activity and histopathology of frontal neocortex from biopsies of demented patients. J Neurol Sci 57: 191-202
16. Braak E, Braak H, Mandelkow EM (1994) A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol 87: 554-567
17. Braak H, Braak E (1991) Demonstration of amyloid deposits and neurofibrillary changes in whole brain sections. Brain Pathol 1: 213-216
18. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82: 239-259
19. Braak H, Braak E (1998) Cortical destruction and cell death in Alzheimer's disease. In: Koliatsos VE, Ratan RR (eds) Cell death and diseases of the nervous system. Humana Press, Totowa, pp 497-550
20. Braak H, Braak E (1998) Evolution of neuronal changes in the course of Alzheimer's disease. J Neural Transm Suppl 53: 127-140
21. Braak H, Braak E, Ohm T, Bohl J (1988) Silver impregnation of Alzheimer's neurofibrillary changes counterstained for basophilic material and lipofuscin pigment. Stain Technol 63: 197-200
22. Braak H, Griffing K, Braak E (1997) Neuroanatomy of Alzheimer's disease. Alzheimer Res 3: 235-247
23. Campbell SK, Switzer RC. Martin TL (1987) Alzheimer's plaques and tangles: a controlled and enhanced silver staining method. Soc Neurosci Abstr 13: 678
24. Cataldo AM, Hamilton DJ, Nixon RA (1994) Lysosomal abnormalities in degenerating neurons link neuronal compromise to senile plaque development in Alzheimer disease. Brain Res 640: 68-80
25. Chozick B (1987) The nucleus basalis of Meynert in neurological dementing disease: a review. Int J Neurosci 37: 31-48
26. Coyle JT, Price DL, DeLong MR (1983) Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 219: 1184-1190
27. Cullen KM, Halliday GM (1998) Neurofibrillary degeneration and cell loss in the nucleus basalis in comparison to cortical Alzheimer pathology. Neurobiol Aging 19: 297-306
28. Davies P, Maloney AJ (1976) Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet II: 1403
29. Divac I (1975) Magnocellular nuclei of the basal forebrain project to neocortex, brain stem, and olfactory bulb. Review of some functional correlates. Brain Res 93: 385-398
30. Duong T, Doucette T, Zidenberg NA, Jacobs RW, Scheibel AB (1993) Microtubule-associated proteins tau and amyloid P component in Alzheimer's disease. Brain Res 603: 74-86
31. Endoh R, Ogawara M, Iwatsubo T, Nakano I, Mori H (1993) Lack of the carboxyl-terminal sequence of tau in ghost tangles of Alzheimer's disease. Brain Res 601: 164-172
32. Francis PT, Palmer AM, Snape M, Wilcock GK (1999) The cholinergic hypothesis of Alzheimer's disease: a review of progress. J Neurol Neurosurg Psychiat 66: 137-147
33. Gallyas F (1971) Silver staining of Alzheimer's neurofibrillary changes by means of physical development. Acta Morph Acad Sci Hung 19: 1-8
34. German DC, White CL, Sparkman DR (1987) Alzheimer's disease: neurofibrillary tangles in nuclei that project to the cerebral cortex. Neurosci 21: 305-312
35. Goedert M, Jakes R, Vanmechelen E (1995) Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205. Neurosci Lett 189: 167-170
36. Gomez-Ramos P, Moran MA (1998) Ultrastructural aspects of neurofibrillary tangle formation in aging and Alzheimer's disease. Microsc Res Tech 43: 49-58
37. Halliday GM, Cullen KM, Cairns MJ (1993) Quantitation and three-dimensional reconstruction of Ch4 nucleus in the human basal forebrain. Synapse 15: 1-16
38. Hardy JA, Higgins GA (1992) Alzheimer's disease: the amyloid cascade hypothesis. Science 256: 184-185
39. Hatanpää K, Brady DR, Stoll J, Rapoport SI, Chandrasekaran K (1996) Neuronal activity and early neurofibrillary tangles in Alzheimer's disease. Ann Neurol 40: 411-420
40. Hyman BT, Trojanowski JQ (1997) Editorial on consensus recommendations for the postmortem diagnosis of Alzheimer disease from the National Institute on Aging and the Reagan Institute working group on diagnostic criteria for the neuropatholgical assessment of Alzheimer disease. J Neuropathol Exp Neurol 56: 1095-1097
41. Kim KS, Wen GY, Bancher C, Chen CMJ, Sapienza VJ, Hong H, Wisniewski HM (1990) Detection and quantitation of amyloid β-peptide with 2 monoclonal antibodies. Neurosci Res Commun 7: 113-122
42. Leontovich TA (1973) Methodik zur quantitativen Beschreibung subcorticaler Neurone. J Hirnforsch 14: 59-87
43. Leontovich TA (1975) Quantitative analysis and classification of subcortical forebrain neurons. In: Santini M (ed) Golgi centennial Symposium. Proceedings. Raven Press. New York, pp 101-122
44. Mann DMA, Yates PO, Marcyniuk B (1984) Changes in nerve cells of the nucleus basalis of Meynert in Alzheimer's disease and their relationship to ageing and to the accumulation of lipofuscin pigment. Mech Ageing Dev 25: 189-204
45. McGeer PL, McGeer EG, Suzuki J, Dolman CE, Nagai T (1984) Aging, Alzheimer's disease and the cholinergic system of the basal forebrain. Neurology 34: 741-745
46. Mercken M, Vandermeeren M, Lübke U, Six J, Boons J, Van de Voorde A, Martin JJ, Gheuens J (1992) Monoclonal antibodies with selective specifity for Alzheimer tau are directed against phosphatase-sensitive epitopes. Acta Neuropathol 84: 265-272
47. Mesulam MM (1986) Alzheimer plaques and cortical cholinergic innervation. Neuroscience 17: 275-276
48. Mesulam MM, Geula C (1988) Nucleus basalis (Ch4) and cortical cholinergic innervation in the human brain: observations based on the distribution of acetylcholinesterase and choline acetyltransferase. J Comp Neurol 275: 216-240
49. Mesulam MM, Mufson EJ, Levey AI, Wainer BH (1983) Cholinergic innervation of cortex by basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (substantia innominata), and hypothalamus in the rhesus monkey. J Comp Neurol 214: 170-197
50. Morsch R, Simon W, Coleman PD (1999) Neurons may live for decades with neurofibrillary tangles. J Neuropathol Exp Neurol 58: 188-197
51. Nagy Z, Vatter Bittner B, Braak H, Braak E. Yilmazer DM, Schultz C, Hanke J (1997) Staging of Alzheimer-type pathology: an interrater-intrarater study. Dement Geriatr Cogn Disord 8: 248-251
52. Pearson RCA, Powell TPS (1987) Anterograde vs. retrograde degeneration of the nucleus basalis medialis in Alzheimer's disease. J Neural Transm Suppl 24: 139-146
53. Rudelli RD, Ambler MW, Wisniewski HM (1984) Morphology and distribution of Alzheimer neuritic (senile) and amyloid plaques in striatum and diencephalon. Acta Neuropathol (Berl) 64: 273-281
54. Saper CB, German DC, White CL (1985) Neuronal pathology in the nucleus basalis and associated cell groups in senile dementia of the Alzheimer's type: possible role in cell loss. Neurology 35: 1089-1095
55. Ulfig N, Braak H (1989) Neuronal types and their percent distribution within the magnocellular nuclei of the human basal forebrain. Acta Anat (Basel) 134: 237-241
56. Van de Nes JAP, Kamphorst W, Ravid R, Swaab DF (1998) Comparison of β-protein/A4 deposits and Alz-50-stained cytoskeletal changes in the hypothalamus and adjoining areas of Alzheimer's disease patients: amorphic plaques and cytoskeletal changes occur independently. Acta Neuropathol 96: 129-138
57. Weinstock M (1995) The pharmacotherapy of Alzheimer's disease based on the cholinergic hypothesis: an update. Neurodegeneration 4: 349-356
58. Whitehouse PJ, Price DL, Clark AW, Coyle JT, DeLong MR (1981) Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann Neurol 10: 122-126
59. Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, DeLong MR (1982) Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 215: 1237-1239